128 related articles for article (PubMed ID: 33372909)
1. [Intestinal microbiome as a predictor of the anti-PD-1 therapy success: metagenomic data analysis].
Fedorov DE; Olekhnovich EI; Pavlenko AV; Klimina KM; Pokataev IA; Manolov AI; Konanov DN; Veselovsky VA; Ilina EN
Biomed Khim; 2020 Nov; 66(6):502-507. PubMed ID: 33372909
[TBL] [Abstract][Full Text] [Related]
2. Relating the gut metagenome and metatranscriptome to immunotherapy responses in melanoma patients.
Peters BA; Wilson M; Moran U; Pavlick A; Izsak A; Wechter T; Weber JS; Osman I; Ahn J
Genome Med; 2019 Oct; 11(1):61. PubMed ID: 31597568
[TBL] [Abstract][Full Text] [Related]
3. Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients.
Gopalakrishnan V; Spencer CN; Nezi L; Reuben A; Andrews MC; Karpinets TV; Prieto PA; Vicente D; Hoffman K; Wei SC; Cogdill AP; Zhao L; Hudgens CW; Hutchinson DS; Manzo T; Petaccia de Macedo M; Cotechini T; Kumar T; Chen WS; Reddy SM; Szczepaniak Sloane R; Galloway-Pena J; Jiang H; Chen PL; Shpall EJ; Rezvani K; Alousi AM; Chemaly RF; Shelburne S; Vence LM; Okhuysen PC; Jensen VB; Swennes AG; McAllister F; Marcelo Riquelme Sanchez E; Zhang Y; Le Chatelier E; Zitvogel L; Pons N; Austin-Breneman JL; Haydu LE; Burton EM; Gardner JM; Sirmans E; Hu J; Lazar AJ; Tsujikawa T; Diab A; Tawbi H; Glitza IC; Hwu WJ; Patel SP; Woodman SE; Amaria RN; Davies MA; Gershenwald JE; Hwu P; Lee JE; Zhang J; Coussens LM; Cooper ZA; Futreal PA; Daniel CR; Ajami NJ; Petrosino JF; Tetzlaff MT; Sharma P; Allison JP; Jenq RR; Wargo JA
Science; 2018 Jan; 359(6371):97-103. PubMed ID: 29097493
[TBL] [Abstract][Full Text] [Related]
4. Consistent Stool Metagenomic Biomarkers Associated with the Response To Melanoma Immunotherapy.
Olekhnovich EI; Ivanov AB; Babkina AA; Sokolov AA; Ulyantsev VI; Fedorov DE; Ilina EN
mSystems; 2023 Apr; 8(2):e0102322. PubMed ID: 36809182
[TBL] [Abstract][Full Text] [Related]
5. Anti-PD1 in the wonder-gut-land.
Vetizou M; Trinchieri G
Cell Res; 2018 Mar; 28(3):263-264. PubMed ID: 29336431
[TBL] [Abstract][Full Text] [Related]
6. Meta-analysis of the gut microbiota in predicting response to cancer immunotherapy in metastatic melanoma.
Limeta A; Ji B; Levin M; Gatto F; Nielsen J
JCI Insight; 2020 Dec; 5(23):. PubMed ID: 33268597
[TBL] [Abstract][Full Text] [Related]
7. Gut microbiome affects the response to anti-PD-1 immunotherapy in patients with hepatocellular carcinoma.
Zheng Y; Wang T; Tu X; Huang Y; Zhang H; Tan D; Jiang W; Cai S; Zhao P; Song R; Li P; Qin N; Fang W
J Immunother Cancer; 2019 Jul; 7(1):193. PubMed ID: 31337439
[TBL] [Abstract][Full Text] [Related]
8. The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients.
Matson V; Fessler J; Bao R; Chongsuwat T; Zha Y; Alegre ML; Luke JJ; Gajewski TF
Science; 2018 Jan; 359(6371):104-108. PubMed ID: 29302014
[TBL] [Abstract][Full Text] [Related]
9. Intestinal microbiota domination under extreme selective pressures characterized by metagenomic read cloud sequencing and assembly.
Kang JB; Siranosian BA; Moss EL; Banaei N; Andermann TM; Bhatt AS
BMC Bioinformatics; 2019 Dec; 20(Suppl 16):585. PubMed ID: 31787070
[TBL] [Abstract][Full Text] [Related]
10. Functional dynamics of bacterial species in the mouse gut microbiome revealed by metagenomic and metatranscriptomic analyses.
Chung YW; Gwak HJ; Moon S; Rho M; Ryu JH
PLoS One; 2020; 15(1):e0227886. PubMed ID: 31978162
[TBL] [Abstract][Full Text] [Related]
11. The Clinical Link between Human Intestinal Microbiota and Systemic Cancer Therapy.
Aarnoutse R; Ziemons J; Penders J; Rensen SS; de Vos-Geelen J; Smidt ML
Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31450659
[TBL] [Abstract][Full Text] [Related]
12. Roles of intestinal microbiota in response to cancer immunotherapy.
Cong J; Zhang X
Eur J Clin Microbiol Infect Dis; 2018 Dec; 37(12):2235-2240. PubMed ID: 30209679
[TBL] [Abstract][Full Text] [Related]
13. Microbiota and cancer immunotherapy: in search of microbial signals.
Gharaibeh RZ; Jobin C
Gut; 2019 Mar; 68(3):385-388. PubMed ID: 30530851
[No Abstract] [Full Text] [Related]
14. Microbiome: Gut microbiota sways response to cancer immunotherapy.
York A
Nat Rev Microbiol; 2018 Mar; 16(3):121. PubMed ID: 29355853
[No Abstract] [Full Text] [Related]
15. Modulation of Gut Microbiota: A Novel Paradigm of Enhancing the Efficacy of Programmed Death-1 and Programmed Death Ligand-1 Blockade Therapy.
Wang Y; Ma R; Liu F; Lee SA; Zhang L
Front Immunol; 2018; 9():374. PubMed ID: 29556232
[TBL] [Abstract][Full Text] [Related]
16. The gut microbiota and immune checkpoint inhibitors.
Humphries A; Daud A
Hum Vaccin Immunother; 2018; 14(9):2178-2182. PubMed ID: 29494275
[TBL] [Abstract][Full Text] [Related]
17. Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors.
Routy B; Le Chatelier E; Derosa L; Duong CPM; Alou MT; Daillère R; Fluckiger A; Messaoudene M; Rauber C; Roberti MP; Fidelle M; Flament C; Poirier-Colame V; Opolon P; Klein C; Iribarren K; Mondragón L; Jacquelot N; Qu B; Ferrere G; Clémenson C; Mezquita L; Masip JR; Naltet C; Brosseau S; Kaderbhai C; Richard C; Rizvi H; Levenez F; Galleron N; Quinquis B; Pons N; Ryffel B; Minard-Colin V; Gonin P; Soria JC; Deutsch E; Loriot Y; Ghiringhelli F; Zalcman G; Goldwasser F; Escudier B; Hellmann MD; Eggermont A; Raoult D; Albiges L; Kroemer G; Zitvogel L
Science; 2018 Jan; 359(6371):91-97. PubMed ID: 29097494
[TBL] [Abstract][Full Text] [Related]
18. Intestinal microbiota signatures of clinical response and immune-related adverse events in melanoma patients treated with anti-PD-1.
McCulloch JA; Davar D; Rodrigues RR; Badger JH; Fang JR; Cole AM; Balaji AK; Vetizou M; Prescott SM; Fernandes MR; Costa RGF; Yuan W; Salcedo R; Bahadiroglu E; Roy S; DeBlasio RN; Morrison RM; Chauvin JM; Ding Q; Zidi B; Lowin A; Chakka S; Gao W; Pagliano O; Ernst SJ; Rose A; Newman NK; Morgun A; Zarour HM; Trinchieri G; Dzutsev AK
Nat Med; 2022 Mar; 28(3):545-556. PubMed ID: 35228752
[TBL] [Abstract][Full Text] [Related]
19. [Intestinal microbiom modulates the response to antitumor immunotherapy].
Olekhnovich EI; Manolov AI; Pavlenko AV; Konanov DN; Fedorov DE; Tikhonova PO; Glushchenko OE; Ilina EN
Biomed Khim; 2020 Jan; 66(1):54-63. PubMed ID: 32116226
[TBL] [Abstract][Full Text] [Related]
20. The intimate relationship between gut microbiota and cancer immunotherapy.
Elkrief A; Derosa L; Zitvogel L; Kroemer G; Routy B
Gut Microbes; 2019; 10(3):424-428. PubMed ID: 30339501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
